Sun Pharma Advanced slips 5% on halting Parkinson#39;s drug trial

The Sun Pharma Advanced Research Company stock has gained 40 percent this year against a 4 percent rise in the benchmark Nifty50

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *